Preliminary Final Report

• 14% increase in total operating revenue to $2.31 billion
• 24% rise in net profit after tax to $468.5 million
• 8% growth in Homecare revenue to $802.7 million
• Dividend increased by 22% to 52.0 cents per share
• Outlook for FY2027: revenue $2.45B-$2.57B, net profit $500M-$550M

Fisher & Paykel Healthcare Corporation Limited announced its financial results for the full year ended 31 March 2026. The company reported a total operating revenue of $2.31 billion, a 14% increase from the previous financial year, or 12% in constant currency. Net profit after tax was $468.5 million, a 24% increase over the 2025 financial year, or 28% in constant currency. The Hospital product group, which includes products used in respiratory, acute, and surgical care, saw revenue of $1.51 billion, up 18% from the previous financial year, or 15% in constant currency. Sales of hospital consumables were up 16% over the prior financial year, or 14% in constant currency. The Homecare product group, which includes products used in the treatment of obstructive sleep apnea (OSA) and respiratory support in the home, reported revenue of $802.7 million, an increase of 8% from the previous financial year, or 7% in constant currency. OSA masks revenue was up 7% for the full year, or 5% in constant currency. The company's gross margin improved to 63.7%, an increase of 80 basis points, or 122 basis points in constant currency. Fisher & Paykel Healthcare invested $235.5 million in research and development and also progressed construction on its fifth building on its East Tāmaki campus, which will add more space for product development, as well as additional manufacturing and warehousing areas. The company expects full-year operating revenue for the 2027 financial year to be in the range of approximately $2.45 billion to $2.57 billion, and net profit after tax to be in the range of approximately $500 million to $550 million.

FY2027: Revenue $2.45B-$2.57B, Net Profit $500M-$550M

The company expects full-year operating revenue for the 2027 financial year to be in the range of approximately $2.45 billion to $2.57 billion, and net profit after tax to be in the range of approximately $500 million to $550 million.